CEPI provided support for the Tumaini trial, where a Merck vaccine is being administered in the Democratic Republic of the Congo.

1 report, 1 independent Updated Sat 00:00

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Democratic Republic of the Congo Merck Coalition for Epidemic Preparedness Innovations

Keep exploring

Part of

Vaccine trials are being conducted in Africa, alongside WHO estimates of the disease burden. All 2 developments

Within Soligenix, Inc. collaborated with John A. Burns School of Medicine on vaccine development relevant for virus-endemic countries in Africa.

The entities involved

Democratic Republic of the Congo
country in Central Africa
- Borr Drilling secured new contracts in West Africa and Congo, while AI stocks are noted to benefit from Trump-era tariffs.11:10
- An Ebola case has been linked to travel originating from the Democratic Republic of the Congo into Kenya.03:25
Merck
public company in Indonesia
- Moderna and Merck announced the successful outcome of their Phase 3 combined treatment trials involving a new cancer vaccine and Keytruda.12:39
- AbbVie, Eli Lilly, and Merck are broadening their therapeutic reach.10:21
Coalition for Epidemic Preparedness Innovations
Public-private organization for vaccine development

Nothing else this week.

Related events

The administration is seeking facilities and international cooperation regarding Ebola preparedness for patients leaving the DRC.Jun 7

Coverage

Newest first; wire copies grouped

Sat 00:00riotimesonline.com